371 related articles for article (PubMed ID: 16837569)
1. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.
Jigorel E; Le Vee M; Boursier-Neyret C; Parmentier Y; Fardel O
Drug Metab Dispos; 2006 Oct; 34(10):1756-63. PubMed ID: 16837569
[TBL] [Abstract][Full Text] [Related]
2. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
[TBL] [Abstract][Full Text] [Related]
3. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways.
Li L; Stanton JD; Tolson AH; Luo Y; Wang H
Pharm Res; 2009 Apr; 26(4):872-82. PubMed ID: 19034627
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.
Xu S; Weerachayaphorn J; Cai SY; Soroka CJ; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G126-35. PubMed ID: 20395535
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes.
Le Vee M; Lecureur V; Moreau A; Stieger B; Fardel O
Drug Metab Dispos; 2009 Nov; 37(11):2228-35. PubMed ID: 19661216
[TBL] [Abstract][Full Text] [Related]
6. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways.
Cheng X; Maher J; Dieter MZ; Klaassen CD
Drug Metab Dispos; 2005 Sep; 33(9):1276-82. PubMed ID: 15919853
[TBL] [Abstract][Full Text] [Related]
8. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver.
Hagenbuch N; Reichel C; Stieger B; Cattori V; Fattinger KE; Landmann L; Meier PJ; Kullak-Ublick GA
J Hepatol; 2001 Jun; 34(6):881-7. PubMed ID: 11451172
[TBL] [Abstract][Full Text] [Related]
9. Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.
Beilke LD; Besselsen DG; Cheng Q; Kulkarni S; Slitt AL; Cherrington NJ
Toxicol Sci; 2008 Mar; 102(1):196-204. PubMed ID: 18032408
[TBL] [Abstract][Full Text] [Related]
10. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.
Le Vee M; Lecureur V; Stieger B; Fardel O
Drug Metab Dispos; 2009 Mar; 37(3):685-93. PubMed ID: 19074973
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.
Martin P; Riley R; Back DJ; Owen A
Br J Pharmacol; 2008 Feb; 153(4):805-19. PubMed ID: 18037906
[TBL] [Abstract][Full Text] [Related]
12. Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes.
Jørgensen L; Van Beek J; Lund S; Schousboe A; Badolo L
Eur J Pharm Sci; 2007 Feb; 30(2):181-9. PubMed ID: 17174077
[TBL] [Abstract][Full Text] [Related]
13. Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver.
Maher JM; Cheng X; Slitt AL; Dieter MZ; Klaassen CD
Drug Metab Dispos; 2005 Jul; 33(7):956-62. PubMed ID: 15833929
[TBL] [Abstract][Full Text] [Related]
14. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells.
Seithel A; Karlsson J; Hilgendorf C; Björquist A; Ungell AL
Eur J Pharm Sci; 2006 Jul; 28(4):291-9. PubMed ID: 16704924
[TBL] [Abstract][Full Text] [Related]
15. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
Fardel O; Payen L; Courtois A; Vernhet L; Lecureur V
Toxicology; 2001 Oct; 167(1):37-46. PubMed ID: 11557128
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
17. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
18. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
19. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
[TBL] [Abstract][Full Text] [Related]
20. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Xu C; Li CY; Kong AN
Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
